Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2020.CA Cancer J Clin. 2020; 70: 7-30
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States.Cancer Res. 2014; 74: 2913-2921
- Two pathogenetic types of endometrial carcinoma.Gynecol Oncol. 1983; 15: 10-17
- Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.Am J Obstet Gynecol. 2008; 198: 218.e1-6
- Uterine neoplasms (Version 2.2020).(Available at:) (Accessed September 22, 2020)
- Limited public knowledge of obesity and endometrial cancer risk: what women know.Obstet Gynecol. 2008; 112: 835-842
- Knowledge of endometrial cancer risk factors in a general gynecologic population.Gynecol Oncol. 2020; 158: 137-142
- Effects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis.Obes Surg. 2020; 30: 1265-1272
- Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.Gynecol Oncol. 2018; 149: 127-132
- PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) trial: a feasibility study.Cancer Prev Res. 2020; https://doi.org/10.1158/1940-6207.CAPR-20-0248
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).Endocr Relat Cancer. 2008; 15: 485-497
- Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.Cancer Epidemiol Biomarkers Prev. 2010; 19: 3119-3130
- Global burden of cancer attributable to high body-mass index in 2012: a population-based study.Lancet Oncol. 2015; 16: 36-46
- Obesity and Endometrial Cancer.Recent Results Cancer Res. 2016; 208: 107-136
- Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2014; 20: 748-758
- Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.J Natl Cancer Inst. 1994; 86: 527-537
- Genetic/Familial High-Risk Assessment: Colorectal (Version 1.2021).(Available at:) (Accessed September 22, 2020)
- The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.Cancer Epidemiol Biomarkers Prev. 2015; 24: 1407-1415
- Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.Am J Obstet Gynecol. 2018; 219: 593.e1-14
- The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women.Ethn Dis. 2020; 30: 543-552
- Ries LAG, Young JL, Keel GE, et al (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics.(Available at:) (Accessed December 24, 2020)
- Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.JAMA Intern Med. 2018; 178: 1210-1222
- Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding.Eur J Cancer. 2001; 37: 64-71
ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol 2018;131(5):e124-e129.
- Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.Gynecol Oncol. 2003; 91: 154-159
- Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.Cancer Prev Res Phila Pa. 2013; 6: 774-781
- Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.J Natl Cancer Inst. 2017; 109https://doi.org/10.1093/jnci/djx030
- Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.Front Oncol. 2020; 10: 559016
- Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.Gynecol Oncol. 2015; 137: 14-22
- Assessment of Cervicovaginal Cancer Antigen 125 Levels: A Preliminary Study for Endometrial Cancer Screening.Gynecol Obstet Invest. 2016; 81: 518-522
- Measuring PC activity in endocervical swab may provide a simple and non-invasive method to detect endometrial cancer in post-menopausal women.Oncotarget. 2016; 7: 46573-46578
- Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.Sci Transl Med. 2013; 5: 167ra4
- Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.Sci Transl Med. 2018; 10https://doi.org/10.1126/scitranslmed.aap8793
- Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.PLoS Med. 2016; 13: e1002206
- Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer. 2015; 136: E359-E386
- Inherited Mutations in Women With Ovarian Carcinoma.JAMA Oncol. 2016; 2: 482-490
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Cancer. 2005; 104: 2807-2816
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.JAMA. 2017; 317: 2402-2416
- Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2018; 319: 588-594
- Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.JAMA. 2011; 305: 2295-2303
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.Lancet. 2016; 387: 945-956
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2021).(Available at:) (Accessed September 22, 2020)
- Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study.J Clin Oncol. 2008; 26: 1331-1337
- Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.J Clin Oncol. 2014; 32: 1547-1553
- Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.J Clin Oncol. 2017; 35: 1411-1420
- Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.Clin Cancer Res. 2017; 23: 3628-3637
- Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.Obstet Gynecol. 2011; 118: 280-288
- Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women.Cancers. 2020; 12https://doi.org/10.3390/cancers12071931
- Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.Gynecol Oncol. 2014; 134: 581-590
- Analysis of circulating tumor cells in ovarian cancer and their clinical value as a biomarker.Cell Physiol Biochem. 2018; 48: 1983-1994
- Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses.Clin Cancer Res. 2017; 23: 2223-2231
- Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.PLoS One. 2015; 10: e0145754
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Hum Pathol. 2011; 42: 918-931
- Cytologic studies of in vivo fallopian tube specimens in patients undergoing salpingo-oophorectomy.CytoJournal. 2020; 17: 19
- Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection.J Vis Exp Jove. 2017; 125https://doi.org/10.3791/55887
- Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases.J Am Soc Cytopathol. 2020; 9: 266-271
- Ovarian cancer detection by DNA methylation in cervical scrapings.Clin Epigenetics. 2019; 11: 166
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer.Am J Clin Pathol. 2012; 137: 516-542
- Human papillomavirus and cervical cancer.Lancet. 2007; 370: 890-907
- Human papillomavirus and cancer: the epidemiological evidence.J Clin Virol. 2000; 19: 1-5
- Biological and clinical aspects of HPV-related cancers.Cancer Biol Med. 2020; 17: 864-878
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Lancet Oncol. 2010; 11: 1048-1056
- A NEW PROCEDURE FOR STAINING VAGINAL SMEARS.Science. 1942; 95: 438-439
- 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.J Low Genit Tract Dis. 2020; 24: 102-131https://doi.org/10.1097/LGT.0000000000000525
- Human Papillomavirus Vaccination.Obstet Gynecol Clin North Am. 2013; 40: 177-197
- Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.CA Cancer J Clin. 2020; 70: 321-346
- HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.AIDS. 2018; 32: 795-808
- Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.(Available at:) (Accessed December 20, 2020)
- Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.J Low Genit Tract Dis. 2019; 23: 87-101
- 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.J Low Genit Tract Dis. 2020; 24: 90-101
- Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.J Low Genit Tract Dis. 2020; 24: 132-143
- A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.J Low Genit Tract Dis. 2020; 24: 144-147
- High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.Int J Cancer. 2013; 132: 2223-2236
- Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.BMC Infect Dis. 2020; 20: 926
- Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.J Virol Methods. 2019; 269: 77-82
Lichter K, Krause D, Xu J, et al. Adjuvant HPV vaccination with surgical excision to prevent recurrent CIN2+: A systematic review and meta-analysis. Featured Poster Session presented at the: Society of Gynecologic Oncology Annual Meeting; March 2020.
Lei J, Ploner A, Elfström KM, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020;383(14):1340-1348.
- Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature.J Oncol. 2020; 2020: 8887672
- Cancer of the vagina.Int J Gynaecol Obstet. 2015; 131: S84-S87
- Age-associated trends of vulvar cancer in the US.Menopause N Y N. 2020; https://doi.org/10.1097/GME.0000000000001687
- Vulvar cancer: epidemiology, clinical presentation, and management options.Int J Womens Health. 2015; 7: 305-313
- Cancer Facts & Figures 2020.Atlanta Am Cancer Soc, 2020
- Committee on Gynecologic Practice of American College Obstetricians and Gynecologists. ACOG Committee Opinion No. 509: Management of vulvar intraepithelial neoplasia.Obstet Gynecol. 2011; 118: 1192-1194
- Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement.JAMA. 2017; 317: 947
- Clinical Guidelines Committee of the American College of Physicians. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians.Ann Intern Med. 2014; 161: 67-72
- Summary of Recommendations for Clinical Preventive Services.(Available at:) (Accessed December 24, 2020)
- Well-Woman Task Force: Components of the Well-Woman Visit.Obstet Gynecol. 2015; 126: 697-701
- ACOG Committee Opinion No. 755 Summary: Well-Woman Visit.Obstet Gynecol. 2018; 132: 1084-1085
- Nucleic Acid Based Tests.(Available at:) (Accessed December 29, 2020)
- A review of the FDA-approved molecular testing platforms for human papillomavirus.J Am Soc Cytopathol. 2019; 8: 284-292
Article info
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
